Partial and full agonists of A1 adenosine receptors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S263100, C514S266400, C536S027300, C536S027630, C544S264000

Reexamination Certificate

active

06946449

ABSTRACT:
Disclosed are novel compounds that are partial and full A1adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, and myocardial infarction.

REFERENCES:
patent: 6258793 (2001-07-01), Palle et al.
patent: 0181129 (1986-05-01), None
patent: 116 401 (2001-01-01), None
patent: WO 99/24449 (1999-05-01), None
patent: WO 99/24450 (1999-05-01), None
patent: WO 99/24451 (1999-05-01), None
patent: WO 99/67262 (1999-12-01), None
patent: WO 99/67262 (1999-12-01), None
patent: WO 01/40243 (2001-06-01), None
Tilburg et al, J. Med. Chem., vol. 42, pp. 1393-1400.
Brackett L E et al: “Functional Characterization of the A2B Adenosine Receptor in NIH 3T3 Fibroblasts”, Biochemical Pharmacology, Pergamon, Oxford, GB, vol. 47, No. 5, 1994, pp. 801-814 XP000942545, ISSN: 0006-2952 abstract.
Marumoto R et al: “Synthesis and Enzymatic Activity of Adenosine 3′ , 5′-Cyclic Phosphate Analogs”, Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan. Tokyo, JP., vol. 27, No. 4, 1979, pp. 990-1003, ISSN: 0009-2363, “chart 3”, p. 992, table 3.
Munro R et al, “Differential expression of adenosine A2A and A2B receptor subtypes of myeloid U937 and THP-1 cells: Adenosine A2B receptor activation selectively stimulates cAMP formation and inhibition of TNFalpha release in THP-1 cells,” Drug Development Research, vol. 44, No. 1, May 1998, pp. 41-47 ISSN: 0272-4391.
Van Der Wenden, E. et al: “5′-Substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor”, J. Med Chem, 1998, 41, pp. 102-108.
Tilburg, E. et al: “N6.5′-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor”, J. Med. Chem, 1999, 42, pp. 1393-1400.
R.M. Smejkal et al. (1989) “Muscarinic receptor subtype specificity of 5′(isobutylthio)-adenosine (SIBA) and its analogues,” Gen. Pharmac., 20(3):385-392, XP008022164.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Partial and full agonists of A1 adenosine receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Partial and full agonists of A1 adenosine receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Partial and full agonists of A1 adenosine receptors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3397203

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.